ArticleScientific reports2024

PD-L1 expression as a predictive biomarker in patients with recurrent or metastatic salivary gland carcinoma treated with pembrolizumab.

Takashi Matsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.